Additionally, inhibitors of PAD4, such as Cl‐amidine, have been explored for their ability to block NET formation and mitigate associated tissue damage in autoimmune disorders like rheumatoid arthritis and SLE.427, 428. Here, PADI4 is linked to rheumatoid arthritis.